喹诺酮类抗菌药不良反应的研究进展

刘倩; 张晶; 林立敏; 卢克鹏; 宋洪涛

doi:10.3969/j.issn.1006-0111.2015.06.007

喹诺酮类抗菌药不良反应的研究进展

doi: 10.3969/j.issn.1006-0111.2015.06.007

1.
南京军区福州总医院药学科, 福建福州 350025;沈阳药科大学药学院, 辽宁沈阳 110016
2.
南京军区福州总医院药学科, 福建福州 350025

Research progress of adverse drug reaction of quinolone antimicrobial agents

1.
Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
2.
Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China

摘要: 喹诺酮类药物自开发以来由于其抗菌谱广、活性强而受到临床欢迎。其常见的不良反应包括:胃肠道紊乱、神经系统反应、皮肤反应等,大多程度轻微且可自愈。但某些品种上市后因严重的毒副作用而撤出市场,应当引起临床高度重视。笔者通过查阅国内外有关文献,总结其不良反应、发生不良反应的高危因素及在特殊人群中的应用,以期为临床合理用药提供参考。
- 喹诺酮类抗菌药 /
- 不良反应 /
- 特殊人群
Abstract: Quinolones are widely used due to the wide antimicrobial spectrum and strong activity. The common adverse reactions of quinolones include gastrointestinal disturbances, central nervous system reaction, skin reaction, etc. These adverse reactions are mild in severity and self-healing. Since some agents were withdrawn from the market due to severe adverse effects, we should pay more attention to quinolones. Both internal and abroad literatures were reviewed, the adverse effects, the high risk factors of the adverse effects and the application in special population were summarized to provide reference for rational clinical drug use.
- quinolone /
- adverse drug reactions /
- special population

[1]	Tome AM,Filipe A. Quinolones:review of psychiatric and neurological adverse reactions[J]. Drug Saf,2011,34(6):465-484.
[2]	张霞光,李天云. 喹诺酮类抗菌药在临床使用中的不良反应[J].国外医药(抗生素分册),2003,24:30-33.
[3]	Kim J,Ohtani H,Tsujimoto M. Quantitative comparison of the convulsive activity of ombinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents[J].Drug Metab Pharmacok,2009,24(2):167-174.
[4]	陈翠环,潘宁开. 喹诺酮类药物诱发精神症状的回顾性分析[J].实用医技杂志,2008,15(10):1278-1279.
[5]	操银针. 喹诺酮类药物引起神经系统不良反应358例分析[J].医药导报,2007,26(10):1246-1247.
[6]	Ray WA,Murray KT,Hall,et al. Azithromycin and the risk of cardiovascular death[J].N Engl J Med,2012,366:1881-1890.
[7]	Lapi F,Wilchesky M, Kezouh A,et al. Fluoroquinolones and the risk of serious arrhythmia: a population-based study[J].Clin Infect Dis,2012,55:1457-65.
[8]	Adefurin A,Sammons H,Jacqz-Aigrain E,et al. Ciprofloxacin safety in paediatrics: a systematic review[J].Arch Dis Child,2011,96:874-80.
[9]	Schaad UB. Will fluoroquinolones ever be recommended for common infections in children?[J].Pediatr Infect Dis J,2007,26:865-867.
[10]	Pichichero ME,Arguedas A, Dagan R,et al. Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure[J].Clin Infect Dis, 2005,41:470-478.
[11]	Seeger JD,West WA,Fife D,et al. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in amanaged care population[J]. Pharmacoepidemiol Drug Safe,2006,15:784-792.
[12]	Wise BL,Peloquin C,Choi H,et al. Impact of age,obesity,and steroiduse on quinolone-associated tendon disorders[J].Am J Med,2012,125:23-28.
[13]	Mandell LA,Ball P,Tillotson G. Antimicrobial safety and toler ability:differences and dilemmas[J].Clin Infect Dis,2001,32(Suppl):72-79.
[14]	Paterson JM,Mamdani MM, Manno M,et al. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study[J].CMAJ,2012,184:1565-1570.
[15]	Etminan M, Forooghian F,Brophy JM,et al. Oral fluoroquinolones and the risk of retinal detachment[J].JAMA, 201,307:1414-1419.
[16]	Albini TA,Karakousis PC,Abbey AM,et al. Association between oral fluoroquinolones and retinal detachment[J].Am J Ophthalmol, 2012,154:919-921.
[17]	Christ W, Lehnert T,Ulbrich B. Specific toxicologic aspects of the quinolones[J].Rev Infect Dis,1988,10:141-146.
[18]	Kato M,Onodera T. Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats[J].Fundam Appl Toxicol,1988,11 (1):110-119.
[19]	Grady R. Safety profile of quinolone antibiotics in the pediatric population[J].Pediatr Infect Dis,2003,22 (12):1128-1132.
[20]	van der Linden PD, Sturkenboom MC, Herings RM,et al. Fluoroquinolones and risk of achilles tendon disorders:case-control study[J].BMJ,2002, 324(7349):1306-1307.
[21]	Shaughnessy MK,Amundson WH, Kuskowski MA,et al. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection[J].Infect Control Hosp Epidemiol,2013,34:109-116.

[1]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[2]	孙波, 吕宗强, 罗宁, 李荣, 王洪祥, 陈菊祥. Angiopep-2修饰的细菌外囊泡载药系统治疗胶质母细胞瘤效果研究 . 药学实践与服务, 2025, 43(10): 481-490. doi: 10.12206/j.issn.2097-2024.202506017
[3]	冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽. 菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(5): 228-234. doi: 10.12206/j.issn.2097-2024.202407038
[4]	崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华. 肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2025, 43(1): 6-9, 21. doi: 10.12206/j.issn.2097-2024.202404006
[5]	沈娟, 田瑛, 倪明, 刘炬, 于蒙蒙. 喷替酸原料药细菌内毒素限值确定及检查方法学研究 . 药学实践与服务, 2025, 43(12): 1-4. doi: 10.12206/j.issn.2097-2024.202508061
[6]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 213-221. doi: 10.12206/j.issn.2097-2024.202412006
[7]	彭莹, 刘欣, 聂依文, 王歆荷, 年华, 朱建勇. 三种狼毒乙醇提取物对咪喹莫特诱导的银屑病小鼠防治作用研究 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202406029
[8]	王文涛, 高兴, 赵凤平, 郑灿辉, 陈新. 异硒唑酮类化合物在疾病治疗中的作用和化学合成方法 . 药学实践与服务, 2025, 43(8): 367-372. doi: 10.12206/j.issn.2097-2024.202308064
[9]	陈明, 王晨佳, 唐原君, 汪硕闻, 范国荣. 新型靶向抗肿瘤药物呋喹替尼的治疗药物监测方法构建及其临床应用 . 药学实践与服务, 2025, 43(12): 1-4. doi: 10.12206/j.issn.2097-2024.202412043
[10]	郭静, 康金龙, 李强, 赵琳, 刘骥, 徐学武. 利多卡因不同给药途径对麻醉诱导气管插管心血管应激反应的抑制作用 . 药学实践与服务, 2025, 43(6): 303-306. doi: 10.12206/j.issn.2097-2024.202502009
[11]	陈怡君, 王卓, 何苗, 张宇, 田泾. 泌尿系统碎石术抗菌药物预防使用合理管控实践 . 药学实践与服务, 2025, 43(12): 1-5. doi: 10.12206/j.issn.2097-2024.202402034
[12]	王彦, 康乐, 陈文, 方琦, 俞仲望, 曹莉. 基于CiteSpace结合系统评价方法分析药品不良反应自动监测系统的热点及优势 . 药学实践与服务, 2025, 43(): 1-8. doi: 10.12206/j.issn.2097-2024.202501034
[13]	王燕, 方铭, 宋红卫, 钟超, 徐峰, 周婷. 2021−2023年某院药品不良反应的特点分析 . 药学实践与服务, 2025, 43(4): 200-204. doi: 10.12206/j.issn.2097-2024.202404041
[14]	张岩, 李炎君, 刘家荟, 邓娇, 原苑, 张敬一. 药物性肝损伤不良反应分析 . 药学实践与服务, 2025, 43(1): 26-29, 40. doi: 10.12206/j.issn.2097-2024.202404034
[15]	高洁, 林心兰, 王兆骞, 张青亭, 李静静, 张凤. 生物制剂治疗强直性脊柱炎的研究进展 . 药学实践与服务, 2025, 43(7): 320-324. doi: 10.12206/j.issn.2097-2024.202502005
[16]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[17]	陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠. UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
[18]	张莲卿, 骆岩, 杨提, 姚佳晨, 李文艳. 基于FAERS数据库的艾塞那肽微球不良事件信号挖掘与研究 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202403057
[19]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[20]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050

点击查看大图

计量

文章访问数: 4539
HTML全文浏览量: 594
PDF下载量: 292
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

喹诺酮类抗菌药不良反应的研究进展

doi: 10.3969/j.issn.1006-0111.2015.06.007

Research progress of adverse drug reaction of quinolone antimicrobial agents

计量

喹诺酮类抗菌药不良反应的研究进展

doi: 10.3969/j.issn.1006-0111.2015.06.007

1. 南京军区福州总医院药学科, 福建福州 350025;沈阳药科大学药学院, 辽宁沈阳 110016

2. 南京军区福州总医院药学科, 福建福州 350025

English Abstract

Research progress of adverse drug reaction of quinolone antimicrobial agents

1. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

2. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China

全文HTML

目录

留言板

喹诺酮类抗菌药不良反应的研究进展

doi: 10.3969/j.issn.1006-0111.2015.06.007

Research progress of adverse drug reaction of quinolone antimicrobial agents

计量

出版历程

喹诺酮类抗菌药不良反应的研究进展

doi: 10.3969/j.issn.1006-0111.2015.06.007

1. 南京军区福州总医院药学科, 福建 福州 350025;沈阳药科大学药学院, 辽宁 沈阳 110016 2. 南京军区福州总医院药学科, 福建 福州 350025

English Abstract

Research progress of adverse drug reaction of quinolone antimicrobial agents

1. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China 2. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China

全文HTML

目录

1. 南京军区福州总医院药学科, 福建福州 350025;沈阳药科大学药学院, 辽宁沈阳 110016

2. 南京军区福州总医院药学科, 福建福州 350025

1. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

2. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China